By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cardiome Pharma Corp. (Formerly Nortran Pharmaceuticals Inc.) 

6190 Agronomy Road, 6th Floor

Vancouver  British Columbia  V6T 1Z3  Canada
Phone: 604-677-6905 or 800-330-9928
Fax: 604-677-6915


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Cardiome (COM.TO) Announces Agreement With Basilea (BSLN.SW) For Distribution Of Zevtera/Mabelio (Ceftobiprole) In Europe And Israel 9/12/2017 6:21:30 AM
Cardiome (COM.TO) Release: New Data Presented At European Society of Cardiology Congress 2017 Highlights Clinical Benefit Of BRINAVESS 8/30/2017 7:24:43 AM
The FDA Finds Cardiome (COM.TO)'s Brinavess Data Package Insufficient For NDA Resubmission 8/21/2017 6:14:05 AM
Cardiome Pharma Corp. (COM.TO) Reports Second Quarter 2017 Financial Results 8/9/2017 12:15:07 PM
Cardiome Pharma Corp. (COM.TO) To Hold Second Quarter 2017 Financial Results Conference Call On August 8 8/1/2017 2:11:54 PM
Cardiome Pharma Corp. (COM.TO) Announces Health Canada Approval Of AGGRASTAT High Dose Bolus Regimen 7/17/2017 6:28:15 AM
Cardiome Pharma Corp. (COM.TO)'s Partner SteadyMed (STDY) Submits U.S. New Drug Application For TREVYENT For The Treatment Of Pulmonary Arterial Hypertension 7/5/2017 6:53:04 AM
Cardiome Pharma Corp. (COM.TO) Announces Voting Results 6/23/2017 12:18:39 PM
Cardiome Pharma Corp. (COM.TO) Announces Licensing Agreement For XYDALBA (Dalbavancin Hydrochloride) To Support Planned Commercialization In Israel 6/21/2017 6:28:01 AM
Cardiome Pharma Corp. (COM.TO) Announces Commercial Launch Of BRINAVESS (Vernakalant Hydrochloride) In Canada 6/12/2017 7:39:59 AM
12345678910...
//-->